Jan. 3, 2023 -- Prophylactic use of methylprednisolone does not reduce the likelihood of a worse
outcome for infants undergoing surgery with cardiopulmonary bypass
Jan. 3, 2023 - For patients receiving thiazide diuretics, the occurrence of major cardiovascular outcome
events or non-cancer-related deaths is no lower
December 28, 2022 – TG Therapeutics, Inc. has announced the U.S. Food and Drug Administration (FDA) has approved BriumviTM (ublituximab-xiiy) for the treatment